Pharmaceuticals

Oxycodone Drugs Industry Growth Insights: Revenue Forecast to 2030

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the oxycodone drugs market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Oxycodone Drugs Market covering 2026–2035?

The oxycodone drugs market has demonstrated robust growth over recent years. It is anticipated to expand from $5.98 billion in 2025 to $6.38 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.7%. This historic growth is largely attributable to the high prevalence of moderate to severe pain conditions, the widespread utilization of opioids in post-operative care, significant hospital demand for injectable analgesics, the established clinical efficacy of oxycodone, and the limited availability of alternative pain therapies.

The oxycodone drugs market size is anticipated to expand significantly in the coming years, projected to reach $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period is primarily driven by stricter opioid prescribing regulations, the increasing adoption of controlled-release pain management, a rise in cancer and chronic pain incidents, the expansion of pain management clinics, and the development of safer opioid formulations. Key trends expected in this timeframe include a shift toward abuse-deterrent oxycodone formulations, a rising utilization of extended-release pain management therapies, a growing preference for hospital-based opioid administration, an increasing emphasis on prescription monitoring and compliance, and the expansion of generic oxycodone products in regulated markets.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Oxycodone Drugs Market?

The increasing prevalence of orthopedic conditions is anticipated to fuel the expansion of the oxycodone drug market moving ahead. Orthopedic disorders encompass ailments impacting bones, joints, ligaments, tendons, and muscles, frequently leading to persistent pain, restricted movement, and enduring functional limitations. This increase in orthopedic conditions stems from factors like an aging population, inactive lifestyles, obesity, sports-related trauma, and work-related stress. Oxycodone medications facilitate effective pain management by alleviating both acute and chronic orthopedic pain, such as that from fractures, joint damage, and post-operative recovery, by targeting pain receptors within the central nervous system. As an illustration, in February 2024, data from Arthritis Australia, an Australia-based non-profit organization, indicated that in 2025, an estimated 212,136 males and 362,137 females are projected to suffer from rheumatoid arthritis (RA), with these figures anticipated to climb by 2040 to roughly 280,040 males and 479,828 females. Consequently, the expanding challenge of orthopedic disorders is a key driver for the growth of the oxycodone drug market.

What Segments Are Identified Within The Structure Of The Oxycodone Drugs Market?

The oxycodone drugs market covered in this report is segmented –

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone

2) By Dosage Form: Tablets, Capsules, Injections

3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution

2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

What Trends Are Reshaping The Dynamics Of The Oxycodone Drugs Market?

Major companies operating in the oxycodone drug market are focusing on developing advanced abuse-deterrent immediate-release (IR) formulations to lessen the risk of misuse through injection and intranasal administration. These abuse-deterrent IR opioids incorporate physical and chemical barriers that make tablets difficult to crush, dissolve, or manipulate for non-oral routes, thereby enhancing patient safety and reducing diversion. For instance, in October 2024, Protega Pharmaceuticals LLC, a US-based pharmaceutical company, received FDA approval for ROXYBOND™ (oxycodone hydrochloride) 10 mg immediate-release tablets, which feature patented SentryBond abuse-deterrent technology. This technology is engineered to resist physical manipulation and chemical extraction, making the tablets challenging to cut, crush, or dissolve for misuse through intranasal or intravenous routes. As a result, it lowers the potential for abuse while still delivering effective immediate-release pain relief for patients whose severe pain requires opioid therapy when other treatment options are insufficient.

Which Key Market Players Are Investing In Expansion And Innovation Within The Oxycodone Drugs Market?

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Regions Are Poised For Strategic Growth In The Oxycodone Drugs Market?

North America was the largest region in the oxycodone drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oxycodone Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15886&type=smp

Browse Through More Reports Similar to the Global Oxycodone Drugs Market 2026, By The Business Research Company

Oxycodone Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Narcotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795